Literature DB >> 11751203

Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response.

Bernard Meshi1, Timothy Z Vitalis, Diana Ionescu, W Mark Elliott, Chun Liu, Xiang-Dong Wang, Shizu Hayashi, James C Hogg.   

Abstract

This study was designed to test the hypothesis that cigarette smoke-induced inflammation and emphysema are amplified by the presence of latent adenoviral (Ad) infection, and to determine whether this emphysematous process can be reversed by all-trans-retinoic acid (RA) treatment. The results confirm that in guinea pigs, chronic cigarette-smoke exposure caused lesions similar to human centrilobular emphysema. They also show that latent Ad infection combined with cigarette-smoke exposure caused an excess increase in lung volume (P < 0.001), air-space volume (P < 0.001), and lung weight (P < 0.01), and further decrease in surface-to-volume ratio (P < 0.001) compared with smoke exposure alone. RA treatment failed to reverse these emphysematous changes. Analysis of inflammatory response in parenchymal and airway tissue showed that smoking caused an increase of polymorphonuclear leukocytes (PMNs) (P < 0.0002), macrophages (P < 0.001), and CD4 cells (P < 0.0009), and that latent Ad infection independently increased PMNs (P < 0.001), macrophages (P = 0.003), and CD8 cells (P < 0.001). We conclude that latent Ad infection amplifies the emphysematous lung destruction and increases the inflammatory response produced by cigarette-smoke exposure. In this study, the increase in CD4 was associated with cigarette smoke and the increase in CD8 cells with latent Ad infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751203     DOI: 10.1165/ajrcmb.26.1.4253

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  42 in total

Review 1.  Chronic obstructive pulmonary disease * 3: Experimental animal models of pulmonary emphysema.

Authors:  R Mahadeva; S D Shapiro
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 2.  Cigarette smoke inhibits alveolar repair: a mechanism for the development of emphysema.

Authors:  Stephen I Rennard; Shinsaku Togo; Olaf Holz
Journal:  Proc Am Thorac Soc       Date:  2006-11

3.  Implications of the innate immune response to adenovirus and adenoviral vectors.

Authors:  Seth M Gregory; Shoab A Nazir; Jordan P Metcalf
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

Review 4.  Toward therapeutic pulmonary alveolar regeneration in humans.

Authors:  Donald Massaro; Gloria Decarlo Massaro
Journal:  Proc Am Thorac Soc       Date:  2006-11

5.  Hyperpolarized 3He diffusion MRI and histology in pulmonary emphysema.

Authors:  Jason C Woods; Cliff K Choong; Dmitriy A Yablonskiy; John Bentley; Jonathan Wong; John A Pierce; Joel D Cooper; Peter T Macklem; Mark S Conradi; James C Hogg
Journal:  Magn Reson Med       Date:  2006-12       Impact factor: 4.668

6.  β-cryptoxanthin restores nicotine-reduced lung SIRT1 to normal levels and inhibits nicotine-promoted lung tumorigenesis and emphysema in A/J mice.

Authors:  Anita R Iskandar; Chun Liu; Donald E Smith; Kang-Quan Hu; Sang-Woon Choi; Lynne M Ausman; Xiang-Dong Wang
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-28

7.  Simvastatin inhibits induction of matrix metalloproteinase-9 in rat alveolar macrophages exposed to cigarette smoke extract.

Authors:  Sang Eun Kim; Tran Thi Thanh Thuy; Ji Hyun Lee; Jai Youl Ro; Young An Bae; Yoon Kong; Jee Yin Ahn; Dong Soon Lee; Yeon Mock Oh; Sang Do Lee; Yun Song Lee
Journal:  Exp Mol Med       Date:  2009-04-30       Impact factor: 8.718

8.  Hepatitis C virus infection is not an independent risk factor for obstructive lung disease.

Authors:  William A Fischer; Michael B Drummond; Christian A Merlo; David L Thomas; Robert Brown; Shruti H Mehta; Robert A Wise; Greg D Kirk
Journal:  COPD       Date:  2013-07-17       Impact factor: 2.409

9.  Eosinophil and T cell markers predict functional decline in COPD patients.

Authors:  Jeanine M D'Armiento; Steven M Scharf; Michael D Roth; John E Connett; Andrew Ghio; David Sternberg; Jonathan G Goldin; Thomas A Louis; Jenny T Mao; George T O'Connor; Joe W Ramsdell; Andrew L Ries; Neil W Schluger; Frank C Sciurba; Melissa A Skeans; Helen Voelker; Robert E Walter; Christine H Wendt; Gail G Weinmann; Robert A Wise; Robert F Foronjy
Journal:  Respir Res       Date:  2009-11-19

Review 10.  Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease.

Authors:  Sean H Ling; Stephan F van Eeden
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.